News

Gayatri BioOrganics Limited informed the BSE Limited that Venture Capital and Corporate Investments Private Limited issued a certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the mutilation and cancellation of dematerialized securities and updating the company’s records as the registered owner.

Gayatri BioOrganics Limited will close its trading window from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026, for designated persons, immediate relatives, and connected persons, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015; a board meeting will be scheduled to consider and approve the results, and a separate notice will be sent to the BSE Limited.

Gayatri BioOrganics announced that the 35th Annual General Meeting(AGM) of the company will be held on 23 September 2026.

Net Loss of Gayatri BioOrganics reported to Rs 0.10 crore in the quarter ended June 2026 as against net loss of Rs 0.26 crore during the previous quarter ended June 2025. Sales reported to Rs 2.34 crore in the quarter ended June 2026. There were no Sales reported during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales2.340 0 OPM %0.430 - PBDT-0.10-0.26 62 PBT-0.10-0.26 62 NP-0.10-0.26 62 Powered by Capital Market - Live News

Gayatri BioOrganics will hold a meeting of the Board of Directors of the Company on 4 August 2026.